Structure—yeast α-glucosidase inhibitory activity relationship of 9-O-berberrubine carboxylates

[1]  R. Harada,et al.  Promising SARS-CoV-2 main protease inhibitor ligand-binding modes evaluated using LB-PaCS-MD/FMO , 2022, Scientific Reports.

[2]  B. Larijani,et al.  Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes , 2022, Scientific Reports.

[3]  T. Rungrotmongkol,et al.  Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies , 2022, Computational and Structural Biotechnology Journal.

[4]  T. Rungrotmongkol,et al.  Halogenated Baicalein as a Promising Antiviral Agent toward SARS-CoV-2 Main Protease , 2022, J. Chem. Inf. Model..

[5]  Sajda Ashraf,et al.  Thiazole inhibitors of α-glucosidase: Positional isomerism modulates selectivity, enzyme binding and potency of inhibition , 2022, Comput. Biol. Chem..

[6]  Sajda Ashraf,et al.  The 4-(dimethylaminoalkyl)piperazine inhibitors of α-glucosidase: allosteric enzyme inhibition and identification of interacting chemical groups , 2022, Turkish journal of chemistry.

[7]  Diogo Santos-Martins,et al.  AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings , 2021, J. Chem. Inf. Model..

[8]  Sajda Ashraf,et al.  Dithiocarbamate derivatives inhibit α‐glucosidase through an apparent allosteric site on the enzyme , 2021, Chemical biology & drug design.

[9]  V. Fogliano,et al.  Inhibition of α-glucosidases by tea polyphenols in rat intestinal extract and Caco-2 cells grown on Transwell. , 2021, Food chemistry.

[10]  D. Jun,et al.  Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile. , 2020, European journal of medicinal chemistry.

[11]  Sang-Han Lee,et al.  Effects of Synergistic Inhibition on α-glucosidase by Phytoalexins in Soybeans , 2019, Biomolecules.

[12]  Chao-Yun Cai,et al.  Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion. , 2019, European journal of medicinal chemistry.

[13]  Sheng Geng,et al.  Interaction Mechanism of Flavonoids and α-Glucosidase: Experimental and Molecular Modelling Studies , 2019, Foods.

[14]  Jaroslav Koča,et al.  Assessing the Performance of MM/PBSA, MM/GBSA, and QM-MM/GBSA Approaches on Protein/Carbohydrate Complexes: Effect of Implicit Solvent Models, QM Methods, and Entropic Contributions. , 2018, The journal of physical chemistry. B.

[15]  Tianyun Lan,et al.  Novel oxazolxanthone derivatives as a new type of α-glucosidase inhibitor: synthesis, activities, inhibitory modes and synergetic effect. , 2018, Bioorganic & medicinal chemistry.

[16]  Shuo Li,et al.  Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumanii. , 2018, European journal of medicinal chemistry.

[17]  Jian-Dong Jiang,et al.  Synthesis and Identification of Novel Berberine Derivatives as Potent Inhibitors against TNF-α-Induced NF-κB Activation , 2017, Molecules.

[18]  Yong Rao,et al.  Analogues of xanthones--Chalcones and bis-chalcones as α-glucosidase inhibitors and anti-diabetes candidates. , 2017, European journal of medicinal chemistry.

[19]  Xiaohong Wang,et al.  Synthesis and hypoglycemic activity of 9-O-(lipophilic group substituted) berberine derivatives. , 2016, Bioorganic & medicinal chemistry letters.

[20]  Shangjing Guo,et al.  Monodisperse microparticles loaded with the self-assembled berberine-phospholipid complex-based phytosomes for improving oral bioavailability and enhancing hypoglycemic efficiency. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  Yan Liu,et al.  Synthesis of 3-acyloxyxanthone derivatives as α-glucosidase inhibitors: A further insight into the 3-substituents' effect. , 2016, Bioorganic & medicinal chemistry.

[22]  Daniel J. Sindhikara,et al.  A 3D‐RISM/RISM study of the oseltamivir binding efficiency with the wild‐type and resistance‐associated mutant forms of the viral influenza B neuraminidase , 2016, Protein science : a publication of the Protein Society.

[23]  Tsun-Thai Chai,et al.  Water fraction of edible medicinal fern Stenochlaena palustris is a potent α-glucosidase inhibitor with concurrent antioxidant activity. , 2015, Food chemistry.

[24]  Usman Ghani.  Re-exploring promising α-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack. , 2015, European journal of medicinal chemistry.

[25]  P. Phuwapraisirisan,et al.  New arylalkanones from Horsfieldia macrobotrys, effective antidiabetic agents concomitantly inhibiting α-glucosidase and free radicals. , 2015, Bioorganic & medicinal chemistry letters.

[26]  Huamin Zhang,et al.  Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats , 2015, Clinical and experimental hypertension.

[27]  D. Takahashi,et al.  Massively parallel implementation of 3D‐RISM calculation with volumetric 3D‐FFT , 2014, J. Comput. Chem..

[28]  M. Grant,et al.  Inflammation in the pathogenesis of microvascular complications in diabetes , 2012, Front. Endocrin..

[29]  Fumio Hirata,et al.  Modified Anderson Method for Accelerating 3D-RISM Calculations Using Graphics Processing Unit. , 2012, Journal of chemical theory and computation.

[30]  Daiying Zuo,et al.  Berberine acutely inhibits the digestion of maltose in the intestine. , 2012, Journal of ethnopharmacology.

[31]  W. Chavasiri,et al.  Efficient Amidation and Esterification of Phosphoric Acid Using Cl3CCN/ Ph3P , 2011 .

[32]  Y. Wan,et al.  Toward potent α-glucosidase inhibitors based on xanthones: a closer look into the structure-activity correlations. , 2011, European journal of medicinal chemistry.

[33]  Xing Tang,et al.  Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats , 2011, AAPS PharmSciTech.

[34]  N. Asano,et al.  In vitro inhibition of α*-glucosidases and glycogen phosphorylase by catechin gallates in green tea , 2010 .

[35]  S. Majumdar,et al.  Physicochemical Characterization of Berberine Chloride: A Perspective in the Development of a Solution Dosage Form for Oral Delivery , 2010, AAPS PharmSciTech.

[36]  Xiao-dong Liu,et al.  Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

[37]  A. Cicero,et al.  Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results , 2009 .

[38]  Yan Liu,et al.  Synthesis, inhibitory activities, and QSAR study of xanthone derivatives as alpha-glucosidase inhibitors. , 2008, Bioorganic & medicinal chemistry.

[39]  Lin Ma,et al.  Synthesis of xanthone derivatives with extended π-systems as α-glucosidase inhibitors: Insight into the probable binding mode , 2007 .

[40]  N. Nakamura,et al.  Pharmacokinetics of Berberine and Its Main Metabolites in Conventional and Pseudo Germ-Free Rats Determined by Liquid Chromatography/Ion Trap Mass Spectrometry , 2006, Drug Metabolism and Disposition.

[41]  W. Chavasiri,et al.  A practical and efficient method for the preparation of sulfonamides utilizing Cl3CCN/PPh3 , 2006 .

[42]  P. Kollman,et al.  Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.

[43]  Yan Liu,et al.  Synthesis and pharmacological activities of xanthone derivatives as alpha-glucosidase inhibitors. , 2006, Bioorganic & medicinal chemistry.

[44]  Ki Duk Park,et al.  Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents. , 2006, Bioorganic & medicinal chemistry letters.

[45]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[46]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[47]  Nathan A. Baker,et al.  PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..

[48]  J. P. Fawcett,et al.  The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. , 2003, Planta medica.

[49]  F. Hirata,et al.  A replica reference interaction site model theory for a polar molecular liquid sorbed in a disordered microporous material with polar chemical groups , 2001 .

[50]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[51]  Jian-Dong Jiang,et al.  Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1. , 2018, European journal of medicinal chemistry.

[52]  Jin-yi Wu,et al.  Synthesis and anticancer activity of a novel series of 9-O-substituted berberine derivatives: a lipophilic substitute role. , 2013, Bioorganic & medicinal chemistry letters.

[53]  George I. N. Rozvany,et al.  Editorial , 2009 .